Thomas Beetham - Chief Operating Officer at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
VRDN on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Thomas Beetham - trading volume in the past year for Viridian Therapeutics, Inc.\DE

Holdings reported by Thomas Beetham for Viridian Therapeutics, Inc.\DE

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6K $140K $23.41 Sep 27, 2024 Direct
Stock Option (Right to Buy) 474K Oct 30, 2023 Direct Common Stock

Transactions reported by Thomas Beetham for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.